Aims: ALB is the most commonly used drug for the treatment of echinococcosis. The aim of the present study was to evaluate the effect of ALB using the intraoperative and perioperative periods as dual therapy.

Materials And Methods: Material of this retrospective study were the consecutive series of 98 patients operated for hepatic hydatidosis (HC) over a period of 7 years, at a single centre. Clinical examination, ultrasonography (US) and computed tomography (CT) were used for establishing diagnosis. Ninety-eight cases of hepatic hydatidosis were treated by albendazole intraoperatively and postoperatively together with surgery. Perioperative ALB treatment was given in a dose of 12-15 mg/ kg per day in four divided doses. The treatment started 2-28 days before the surgery when the diagnosis was established and continued for 2-24 months postoperatively in a cyclic monthly form. A total of 1.7 mg/mL ALB solution was used intraoperatively. Dual albendazole treatment (DALB) includes preoperative and postoperative oral ALB treatment and intraoperative irrigation of cystic cavity with ALB.

Results: In the follow-up period one patient died and there was one recurrence of hepatic hydatidosis. Morbidity rates were 10.89%.

Conclusion: Results of this study suggest that ALB treatment with HC surgery is effective in the prevention of recurrences and/or secondary hydatidosis.

Key Words: Albendazole, Recurrens Liver hydatic cyst, Surgical treatment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hepatic hydatidosis
12
alb treatment
12
treatment
7
alb
6
role combination
4
combination preand
4
preand postoperative
4
albendazole
4
postoperative albendazole
4
albendazole therapy
4

Similar Publications

Background: Hepato-thoracic hydatid transit (HTT) is an evolutionary complication of hepatic cystic echinococcosis. This study aimed to report the available evidence regarding postoperative complications (POC) and hospital mortality (HM).

Methods: Systematic review.

View Article and Find Full Text PDF

Background: Hepatectomy is historically associated with higher morbidity and mortality, related to intraoperative blood loss and biliary fistulas. Technological advances and improvements in surgical and anesthetic techniques have led to greater safety in performing these surgeries.

Aims: The aim of this study was to analyze morbidity and mortality in patients undergoing hepatectomy.

View Article and Find Full Text PDF

Echinococcosis is caused by larvae, the metacestode stage of the tapeworm , and poses a public health issue in many developing countries. It generally affects a single organ, most commonly the liver or lungs, and rarely involves multiple organs. We present the case of a 24-year-old Indian man living in Portugal, who was admitted to the Emergency Department with left-sided thoracic pain radiating to the back.

View Article and Find Full Text PDF

Rupture of a hydatid cyst can lead to the development of a disseminated form of intra-abdominal cystic echinococcosis if not diagnosed and treated promptly. Anaphylactic shock is a definite indication of cyst rupture. The presented clinical case was a young athlete with a disseminated form of cystic echinococcosis, which was investigated in 2023 at the Syzganov National Scientific Center for Surgery of Kazakhstan.

View Article and Find Full Text PDF

Background: Minimally invasive surgeries are increasingly central to modern medicine, particularly in liver transplantation. These techniques, which offer reduced trauma, precise operations, minimal bleeding, and swift recovery, are, however, unevenly adopted across China. Only a limited number of centers routinely perform minimally invasive donor hepatectomies, indicating a significant imbalance in the development and application of these advanced procedures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!